Combination Chemotherapy in Treating Patients With Multiple Myeloma

NCT00003493 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Multiple Myeloma and Plasma Cell Neoplasm

Interventions

DRUG: dexamethasone
DRUG: pegylated liposomal doxorubicin hydrochloride
DRUG: vincristine sulfate

Sponsor

The Cleveland Clinic